InnoSer is an innovative contract research organization (CRO) operating in The Netherlands and Belgium. They specialize in supporting discovery and preclinical drug development for biotech companies and pharmaceutical developers. With their expertise in various therapeutic areas including Immuno-oncology, Nephrology, Neurology, and Cardio-metabolic diseases, they offer a wide range of services to accelerate research.

InnoSer's services include target validation, hit to lead, lead optimization, preclinical development, pathology, mouse models, facility management and support, colony management, facility management sanitation, and cryopreservation. They also have an InnoSer Acceleration Program (ISAP) that focuses on disease models such as Fragile X syndrome, Vanishing White Matter, Charcot Marie Tooth Disease Type 1A, Infantile Epileptic Encephalopathy, Polycystic Kidney Disease, Alzheimer's Disease, Parkinson's Disease, ALS Disease, Multiple Sclerosis, Spasticity, and Aging. By offering customized solutions and a collaborative approach, InnoSer ensures meaningful, high-quality, and fast results for their clients.

Their team of experts is dedicated to proactive problem-solving and innovation to meet the evolving needs of the industry. Join their mission to build a smart road to better health by partnering with InnoSer